US Stock MarketDetailed Quotes

SLDB Solid Biosciences

Watchlist

8.0250
+0.3050+3.95%

Trading Sep 13 12:22 ET

309.73MMarket Cap-2439P/E (TTM)

Solid Biosciences Stock Forum

Meltyy

May 16 01:29

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...

Trytosaveabit

Apr 1 06:50

Update

$Solid Biosciences (SLDB.US)$ Solid Biosciences Receives Rare Pediatric Disease Designation From the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
Moomoo 24/7· 1 min ago

Trytosaveabit

Jan 9 12:30

How nice is this?

$Solid Biosciences (SLDB.US)$ So if you took a position PM yesterday and didnt secure profits before it dumped? Well you now have another chance at getting them profits! GL i hope you’re making some bank

Trytosaveabit

Jan 8 09:05

Nice!

$Solid Biosciences (SLDB.US)$ FDA fast track news last month and 100M+ private placement announcement today

Meticulous Trader

Dec 7, 2023 23:50

$Solid Biosciences (SLDB.US)$ consolidating before another round of uptrend 😎🤙🏻👍

I love me

Dec 7, 2023 15:25

$Solid Biosciences (SLDB.US)$ WTF. GREAT NEWS AND IT DIES F$ck this....

Gold_Morgan

Dec 7, 2023 14:19

$Solid Biosciences (SLDB.US)$ the target price is $18.

Trytosaveabit

Dec 7, 2023 13:15

FDA FAST TRACK

$Solid Biosciences (SLDB.US)$ The FDA fast track approval working out nicely

Trytosaveabit

Dec 7, 2023 07:03

News

$Solid Biosciences (SLDB.US)$ Solid Biosciences Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Gene Therapy SGT-003
3 MINUTES AGO, 8:00 AM EST
VIA GLOBENEWSWIRE

淡定的惠特莫爾

Nov 21, 2023 12:14

The Zacks Analyst Blog Highlights Arcellx, Bristol Myers Squibb, Solid Biosciences, Vertex Pharmaceuticals and CRISPR Therapeutics

$Direxion Daily S&P Biotech Bull 3x Shares ETF (LABU.US)$

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data